首页> 外国专利> Treatment of hepatitis C virus infection with telaprevir (VX-950) in patients who are unresponsive to treatment with peginterferon-alpha-2A / 2B and ribavirin

Treatment of hepatitis C virus infection with telaprevir (VX-950) in patients who are unresponsive to treatment with peginterferon-alpha-2A / 2B and ribavirin

机译:对聚乙二醇干扰素-α-2A/ 2B和利巴韦林无反应的患者,使用telaprevir(VX-950)治疗丙型肝炎病毒感染

摘要

The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.
机译:本发明涉及用于治疗或预防患者的丙型肝炎感染的抗病毒疗法和组合物,并且涉及本文公开的其他方法。本发明还涉及包含组合物和剂型的试剂盒和药物包装。本发明还涉及制备这些组合物,剂量,试剂盒和包装的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号